New generic drug for skin infections is approved by the FDA

FDA officials have approved a generic drug for the treatment of canine and feline skin infections. Cefovecin Sodium for Injection is sponsored by Qilu Animal Health Products Co in Shandong, China.1

Cefovecin Sodium for Injection is an antimicrobial drug used to treat infections, abscesses, and wounds caused by certain bacterial strains. It is only available with a prescription from a licensed veterinarian and is supplied as a multiuse vial equal to 80 mg/mL when reconstituted with 10 mL of sterile water for injection.1

The generic drug contains cefovecin sodium, the same active ingredient in Convenia (Zoetis Inc), which was approved by the FDA in 2008. Cefovecin Sodium for Injection does not contain inactive ingredients that may significantly affect the bioavailability of cefovecin sodium, according to the FDA.1,2

RELATED: Investigational drug aims to treat equine skin cancer

According to Zoetis, Convenia is indicated for skin infections in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (group G). These infections include secondary superficial pyoderma, abscesses, and wounds.2

In cats, Convenia is indicated for the treatment of skin infections caused by susceptible strains of Pasteurella multocida. These feline infections include wounds and abscesses.2

References

1. FDA approves first generic cefovecin sodium injection treating skin infections in dogs and cats. FDA. June 24, 2025. Accessed June 24, 2025. https://www.fda.gov/animal-veterinary/cvm-updates/fda-approves-first-generic-cefovecin-sodium-injection-treating-skin-infections-dogs-and-cats?utm_medium=email&utm_source=govdelivery
2. Convenia (cefovecin sodium). Zoetis. 2023. Accessed June 24, 2025. https://www.zoetisus.com/products/petcare/convenia/